Clinical Trial Update: Bioequivalence Study of Montelukast Sodium Chewable Tablets 4mg and 5mg Under Fed Condition [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing Montelukast Sodium chewable tablets 4 mg and 5 mg under fed conditions in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma
• Exercise-induced Bronchoconstriction

Drugs mentioned

• Montelukast Sodium chewable tablets (montelukast)

Snippet

Sponsor: Dr. Reddy's Laboratories Limited | Conditions: Healthy | Phase 1 | Status: COMPLETED